-
Posted by
Two Blokes Jun 14 -
Filed in
Stock
-
4 views
Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an early-stage study, an investor note by brokerage Cantor Fitzgerald showed on Friday.
